[Oxaliplatin].
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003110:Colonic Neoplasms / Q000451:nursing*; D006801:Humans; D009944:Organoplatinum Compounds / Q000008:administration & dosage* / Q000009:adverse effects; D000077150:Oxaliplatin; D010190:Pancreatic Neoplasms / Q000451:nursing*; D016896:Treatment Outcome
D009944:Organoplatinum Compounds; D000077150:Oxaliplatin